BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24354664)

  • 21. Bioinspired trimodal macro/micro/nano-porous scaffolds loading rhBMP-2 for complete regeneration of critical size bone defect.
    Tang W; Lin D; Yu Y; Niu H; Guo H; Yuan Y; Liu C
    Acta Biomater; 2016 Mar; 32():309-323. PubMed ID: 26689464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of Chinese hamster ovary cell versus Escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model.
    Lee J; Lee EN; Yoon J; Chung SM; Prasad H; Susin C; Wikesjö UM
    J Periodontol; 2013 Mar; 84(3):415-22. PubMed ID: 22612368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Instrumented Lumbar Corpectomy and Spinal Reconstruction Comparing rhBMP-2/Compression-Resistant Matrix, rhBMP-2/Absorbable Collagen Sponge/Ceramic Granules Mixture, and Autograft in Two Different Devices: A Study in Sheep.
    Toth JM; Schwartz DG; Mobasser JP; Williams J
    Spine (Phila Pa 1976); 2016 Mar; 41(6):E313-22. PubMed ID: 26536446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strut allograft union and remodeling using rhBMP-2 in a spinal corpectomy model.
    White KK; Bawa M; Ahn JS; Farnsworth CL; Faro FD; Mahar AT; Wedemeyer M; Garfin SR; Newton PO
    Spine (Phila Pa 1976); 2005 Jun; 30(12):1386-95. PubMed ID: 15959367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone regeneration using photocrosslinked hydrogel incorporating rhBMP-2 loaded 2-N, 6-O-sulfated chitosan nanoparticles.
    Cao L; Werkmeister JA; Wang J; Glattauer V; McLean KM; Liu C
    Biomaterials; 2014 Mar; 35(9):2730-42. PubMed ID: 24438908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed onset of paralysis and slowed tumor growth following in situ placement of recombinant human bone morphogenetic protein 2 within spine tumors in a rat model of metastatic breast cancer.
    Molina CA; Sarabia-Estrada R; Gokaslan ZL; Witham TF; Bydon A; Wolinsky JP; Sciubba DM
    J Neurosurg Spine; 2012 Apr; 16(4):365-72. PubMed ID: 22264176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
    Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuning the bioactivity of bone morphogenetic protein-2 with surface immobilization strategies.
    Chen R; Yu Y; Zhang W; Pan Y; Wang J; Xiao Y; Liu C
    Acta Biomater; 2018 Oct; 80():108-120. PubMed ID: 30218780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient Local Bone Remodeling Effects of rhBMP-2 in an Ovine Interbody Spine Fusion Model.
    Bae HW; Patel VV; Sardar ZM; Badura JM; Pradhan BB; Seim HB; Turner AS; Toth JM
    J Bone Joint Surg Am; 2016 Dec; 98(24):2061-2070. PubMed ID: 28002369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional printing of rhBMP-2-loaded scaffolds with long-term delivery for enhanced bone regeneration in a rabbit diaphyseal defect.
    Shim JH; Kim SE; Park JY; Kundu J; Kim SW; Kang SS; Cho DW
    Tissue Eng Part A; 2014 Jul; 20(13-14):1980-92. PubMed ID: 24517081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of recombinant human bone morphogenetic protein-2 and -9 on bone formation in rat calvarial critical-size defects.
    Nakamura T; Shirakata Y; Shinohara Y; Miron RJ; Hasegawa-Nakamura K; Fujioka-Kobayashi M; Noguchi K
    Clin Oral Investig; 2017 Dec; 21(9):2671-2679. PubMed ID: 28197731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
    Hsu WK; Polavarapu M; Riaz R; Roc GC; Stock SR; Glicksman ZS; Ghodasra JH; Hsu EL
    J Orthop Res; 2011 Dec; 29(12):1812-9. PubMed ID: 21590717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo comparison of the effects of rhBMP-2 and rhBMP-4 in osteochondral tissue regeneration.
    Lópiz-Morales Y; Abarrategi A; Ramos V; Moreno-Vicente C; López-Durán L; López-Lacomba JL; Marco F
    Eur Cell Mater; 2010 Dec; 20():367-78. PubMed ID: 21154243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fusion performance of low-dose recombinant human bone morphogenetic protein 2 and bone marrow-derived multipotent stromal cells in biodegradable scaffolds: a comparative study in a large animal model of anterior lumbar interbody fusion.
    Abbah SA; Lam CX; Ramruttun AK; Goh JC; Wong HK
    Spine (Phila Pa 1976); 2011 Oct; 36(21):1752-9. PubMed ID: 21673630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow enhances the performance of rhBMP-2 in spinal fusion: a rodent model.
    Bae HW; Zhao L; Kanim LE; Wong P; Marshall D; Delamarter RB
    J Bone Joint Surg Am; 2013 Feb; 95(4):338-47. PubMed ID: 23426768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
    Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
    Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
    J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog.
    Meyer RA; Gruber HE; Howard BA; Tabor OB; Murakami T; Kwiatkowski TC; Wozney JM; Hanley EN
    Spine (Phila Pa 1976); 1999 Apr; 24(8):747-54. PubMed ID: 10222524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
    Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.